Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Aug 7:2018:4763832.
doi: 10.1155/2018/4763832. eCollection 2018.

The Expanding Role of Systemic Therapy in the Management of Hepatocellular Carcinoma

Affiliations
Review

The Expanding Role of Systemic Therapy in the Management of Hepatocellular Carcinoma

Omar Abdel-Rahman et al. Can J Gastroenterol Hepatol. .

Abstract

Hepatocellular carcinoma (HCC) represents a global health problem, with the majority of patients presenting at an advanced or incurable stage. The development of effective systemic therapy options for this disease has been challenging because many HCC patients suffer from underlying liver cirrhosis that precludes the safe delivery of systemic therapy. The current review seeks to provide an overview of the current systemic therapeutic approaches for advanced HCC as well as some of the novel management strategies that are currently being evaluated.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Ferlay J., Soerjomataram I., Dikshit R., et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer. 2014;136(5):E359–E386. doi: 10.1002/ijc.29210. - DOI - PubMed
    1. Mittal S., El-Serag H. B. Epidemiology of hepatocellular carcinoma: consider the population. Journal of Clinical Gastroenterology. 2013;47(1):S2–S6. doi: 10.1097/mcg.0b013e3182872f29. - DOI - PMC - PubMed
    1. Zhu R. X., Seto W.-K., Lai C.-L., Yuen M.-F. Epidemiology of hepatocellular carcinoma in the Asia-Pacific region. Gut and Liver. 2016;10(3):332–339. doi: 10.5009/gnl15257. - DOI - PMC - PubMed
    1. Kansagara D., Papak J., Pasha A. S., et al. Screening for hepatocellular carcinoma in chronic liver disease: a systematic review. Annals of Internal Medicine. 2014;161(4):261–269. doi: 10.7326/M14-0558. - DOI - PubMed
    1. Abdel-Rahman O. Systemic therapy for hepatocellular carcinoma (HCC): from bench to bedside. Journal of the Egyptian National Cancer Institute. 2013;25(4):165–171. doi: 10.1016/j.jnci.2013.08.002. - DOI - PubMed

LinkOut - more resources